Update Reimbursement Scheme Adempas®
As off May 31st 2023, the reimbursement for Adempas® 0.5 mg and 1.0 mg is now also indicated for the treatment of PAH in pediatric...
Reimbursement Scheme Jardiance® - Chronic Kidney Disease
Arrangement for reimbursement by TerugBetaalRegeling Jardiance® (empagliflozin) 10 mg for patients with chronic kidney disease...
Update Reimbursement Scheme Forxiga® - HFpEF
TerugBetaalRegeling Forxiga® (dapagliflozin) 10 mg for patients with symptomatic chronic heart failure with a LVEF ≥ 40% (HFmrEF &...
Reimbursement Scheme Signifor®
The health insurer does not fully reimburse Signifor® 20mg. The producer of this medicine has therefore asked TBR Nederland to...
Update TerugBetaalRegeling Veltassa®, patiromer 8.4g
From May 1, 2023, the use of Veltassa® 8.4g will be fully reimbursed by the health insurer. For this reason the Reimbursement...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine